These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23002183)

  • 1. Reduced expression of STOP/MAP6 in mice leads to cognitive deficits.
    Volle J; Brocard J; Saoud M; Gory-Faure S; Brunelin J; Andrieux A; Suaud-Chagny MF
    Schizophr Bull; 2013 Sep; 39(5):969-78. PubMed ID: 23002183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The deletion of STOP/MAP6 protein in mice triggers highly altered mood and impaired cognitive performances.
    Fournet V; Schweitzer A; Chevarin C; Deloulme JC; Hamon M; Giros B; Andrieux A; Martres MP
    J Neurochem; 2012 Apr; 121(1):99-114. PubMed ID: 22146001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both chronic treatments by epothilone D and fluoxetine increase the short-term memory and differentially alter the mood status of STOP/MAP6 KO mice.
    Fournet V; de Lavilléon G; Schweitzer A; Giros B; Andrieux A; Martres MP
    J Neurochem; 2012 Dec; 123(6):982-96. PubMed ID: 23013328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairments in the STOP null mouse model of schizophrenia.
    Powell KJ; Hori SE; Leslie R; Andrieux A; Schellinck H; Thorne M; Robertson GS
    Behav Neurosci; 2007 Oct; 121(5):826-35. PubMed ID: 17907815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased nesting behavior, selective increases in locomotor activity in a novel environment, and paradoxically increased open arm exploration in Neurogranin knockout mice.
    Nakajima R; Hattori S; Funasaka T; Huang FL; Miyakawa T
    Neuropsychopharmacol Rep; 2021 Mar; 41(1):111-116. PubMed ID: 33270377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The stop null mice model for schizophrenia displays [corrected] cognitive and social deficits partly alleviated by neuroleptics.
    Bégou M; Volle J; Bertrand JB; Brun P; Job D; Schweitzer A; Saoud M; D'Amato T; Andrieux A; Suaud-Chagny MF
    Neuroscience; 2008 Nov; 157(1):29-39. PubMed ID: 18804150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of striatal phenotypes in heterozygous Disc1 mutant mice, a model of haploinsufficiency.
    Baskaran R; Lai CC; Li WY; Tuan LH; Wang CC; Lee LJ; Liu CM; Hwu HG; Lee LJ
    J Comp Neurol; 2020 May; 528(7):1157-1172. PubMed ID: 31721208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of MAP6 deficit, maternal separation and MK801 in female mice: A 3-hit animal model of neurodevelopmental disorder with cognitive deficits.
    Percelay S; Freret T; Turnbull N; Bouet V; Boulouard M
    Behav Brain Res; 2021 Sep; 413():113473. PubMed ID: 34280461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-pubertal emergence of alterations in locomotor activity in stop null mice.
    Bégou M; Brun P; Bertrand JB; Job D; Schweitzer A; D'Amato T; Saoud M; Andrieux A; Suaud-Chagny MF
    Synapse; 2007 Sep; 61(9):689-97. PubMed ID: 17559095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal transport defects of the MAP6 KO mouse - a model of schizophrenia - and alleviation by Epothilone D treatment, as observed using MEMRI.
    Daoust A; Bohic S; Saoudi Y; Debacker C; Gory-Fauré S; Andrieux A; Barbier EL; Deloulme JC
    Neuroimage; 2014 Aug; 96():133-42. PubMed ID: 24704457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New horizons in schizophrenia treatment: autophagy protection is coupled with behavioral improvements in a mouse model of schizophrenia.
    Merenlender-Wagner A; Shemer Z; Touloumi O; Lagoudaki R; Giladi E; Andrieux A; Grigoriadis NC; Gozes I
    Autophagy; 2014; 10(12):2324-32. PubMed ID: 25484074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of synaptic protein mRNAs in STOP (MAP6) mutant mice.
    Eastwood SL; Lyon L; George L; Andrieux A; Job D; Harrison PJ
    J Psychopharmacol; 2007 Aug; 21(6):635-44. PubMed ID: 17050659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAP (davunetide) enhances cognitive behavior in the STOP heterozygous mouse--a microtubule-deficient model of schizophrenia.
    Merenlender-Wagner A; Pikman R; Giladi E; Andrieux A; Gozes I
    Peptides; 2010 Jul; 31(7):1368-73. PubMed ID: 20417241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic administration of atypical antipsychotics improves behavioral and synaptic defects of STOP null mice.
    Delotterie D; Ruiz G; Brocard J; Schweitzer A; Roucard C; Roche Y; Suaud-Chagny MF; Bressand K; Andrieux A
    Psychopharmacology (Berl); 2010 Jan; 208(1):131-41. PubMed ID: 19936716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide synthase mediates the ability of darbepoetin alpha to improve the cognitive performance of STOP null mice.
    Kajitani K; Thorne M; Samson M; Robertson GS
    Neuropsychopharmacology; 2010 Jul; 35(8):1718-28. PubMed ID: 20336057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced Slc1a1 expression is associated with neuroinflammation and impaired sensorimotor gating and cognitive performance in mice: Implications for schizophrenia.
    Afshari P; Yao WD; Middleton FA
    PLoS One; 2017; 12(9):e0183854. PubMed ID: 28886095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Own or dam's genotype? Classical colony breeding may bias spontaneous and stress-challenged activity in DAT-mutant rats.
    Mariano S; Pardo M; Buccheri C; Illiano P; Adinolfi A; Lo Russo SLM; Alleva E; Carbone C; Adriani W
    Dev Psychobiol; 2020 May; 62(4):505-518. PubMed ID: 31599465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D imaging of the brain morphology and connectivity defects in a model of psychiatric disorders: MAP6-KO mice.
    Gimenez U; Boulan B; Mauconduit F; Taurel F; Leclercq M; Denarier E; Brocard J; Gory-Fauré S; Andrieux A; Lahrech H; Deloulme JC
    Sci Rep; 2017 Sep; 7(1):10308. PubMed ID: 28871106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruptions of Sleep/Wake Patterns in the Stable Tubule Only Polypeptide (STOP) Null Mouse Model of Schizophrenia.
    Profitt MF; Deurveilher S; Robertson GS; Rusak B; Semba K
    Schizophr Bull; 2016 Sep; 42(5):1207-15. PubMed ID: 26940700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural effects of high fat diet exposure starting in late adolescence in neuregulin 1 transmembrane domain mutant mice.
    Zieba J; Morris MJ; Karl T
    Behav Brain Res; 2019 Nov; 373():112074. PubMed ID: 31284014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.